Identification of pyroptosis-related genes and long non-coding RNAs signatures in osteosarcoma

被引:0
作者
Jian Zhang
Jianjian Deng
Rui Ding
Jinghong Yuan
Jiahao Liu
Xiaokun Zhao
Tianlong Wu
Jingyu Jia
Xigao Cheng
机构
[1] The Second Affiliated Hospital of Nanchang University,Department of Orthopedics
[2] Institute of Orthopedics of Jiangxi Province,Institute of Minimally Invasive Orthopedics
[3] Nanchang University,undefined
来源
Cancer Cell International | / 22卷
关键词
Osteosarcoma; Pyroptosis; lncRNA; Biomarkers; Prognostic signature;
D O I
暂无
中图分类号
学科分类号
摘要
Osteosarcoma is a highly malignant tumor, with very high disability and fatality rates. However, the overall prognosis is not optimistic. Pyroptosis is a newly discovered cell death modality accompanied by inflammation, which is closely related to varieties of cancers. In this study, the RNA-seq data were downloaded from public databases, the differences in the expression of the pyroptosis-related genes (PRGs) were identified, and the six PRGs signature was established through the univariate and LASSO Cox analysis. The patients were grouped according to the PRGs signature, and the prognosis between the two groups was further compared. In addition, a ten pyroptosis-related lncRNAs (PRLs) prognostic signature was also constructed. Through functional analysis of the differentially expressed genes (DEGs), the immune-related pathways were found to be enriched. The Pearson correlation analysis showed a strong correlation between the pyroptosis-related biomarkers. Finally, we identified a promising biomarker, CHMP4C, which is highly expressed in osteosarcoma. Overexpression of CHMP4C promoted the proliferation, migration and invasion of the osteosarcoma cell. Our results thus provide new evidence for exploring prognostic biomarkers and therapeutic targets of osteosarcoma.
引用
收藏
相关论文
共 413 条
[1]  
Luetke A(2014)Osteosarcoma treatment—where do we stand? A state of the art review Cancer Treat Rev 40 523-32
[2]  
Meyers PA(2014)Osteosarcoma Cancer Treat Res 162 65-92
[3]  
Lewis I(2010)Osteosarcoma Ann Oncol 21 vii320-325
[4]  
Juergens H(2013)SEOM clinical guidelines for the treatment of osteosarcoma in adults-2013 Clin Transl Oncol 15 1037-43
[5]  
Moore DD(2017)Pyroptosis: gasdermin-mediated programmed necrotic cell death Trends Biochem Sci 42 245-54
[6]  
Luu HH(2017)Gasdermins: Effectors of Pyroptosis Trends Cell Biol 27 673-84
[7]  
Ritter J(2016)Pyroptosis Curr Biol 26 R568-r572-78
[8]  
Bielack SS(2016)GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death Embo j 35 1766-20
[9]  
Redondo A(2016)Inflammasomes: mechanism of assembly, regulation and signalling Nat Rev Immunol 16 407-26
[10]  
Cruz J(2013)Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection Curr Opin Microbiol 16 319-75